Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model.
Nov 2008 - Clin. Immunol.; 129(3):1521-7035 [PMID:18845485]
[Teitz-Tennenbaum S] [Li Q] [Davis MA] [Chang AE]

Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma.
Jun 2008 - J. Immunother.; 31(6):1524-9557 [PMID:18528294]
[Redman BG] [Chang AE] [Whitfield J] [Esper P] [Jiang G] [Braun T] [Roessler B] [Mulé JJ]

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.
Apr 2008 - J. Immunother.; 31(4):1524-9557 [PMID:18391761]
[Teitz-Tennenbaum S] [Li Q] [Okuyama R] [Davis MA] [Sun R] [Whitfield J] [Knibbs RN] [Stoolman LM] [Chang AE]

Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression.
Jun 2007 - Clin. Immunol.; 123(3):1521-6616 [PMID:17449328]
[Huang J] [Wang Y] [Guo J] [Lu H] [Lin X] [Ma L] [Teitz-Tennenbaum S] [Chang AE] [Li Q]

Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.
Dec 2001 - Cancer Res.; 61(23):0008-5472 [PMID:11731436]
[Geiger JD] [Hutchinson RJ] [Hohenkirk LF] [McKenna EA] [Yanik GA] [Levine JE] [Chang AE] [Braun TM] [Mulé JJ]